We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXP icon
951
LXP Industrial Trust
LXP
$3.58B
$1.2M 0.01%
22,748
+1,948
+9% +$98.2K
MAC icon
952
Macerich
MAC
$6.99B
$1.2M 0.01%
133,553
+70,305
+111% +$545K
MUR icon
953
Murphy Oil
MUR
$4.99B
$1.2M 0.01%
86,741
+1,002
+1% +$11.5K
R icon
954
Ryder
R
$10.1B
$1.2M 0.01%
31,911
+1,321
+4% +$43.8K
CRS icon
955
Carpenter Technology
CRS
$26.6B
$1.2M 0.01%
49,234
+997
+2% +$22.1K
WWE
956
DELISTED
World Wrestling Entertainment
WWE
$1.2M 0.01%
27,504
+263
+1% +$11.3K
STAA icon
957
STAAR Surgical
STAA
$1.26B
$1.2M 0.01%
19,419
TRN icon
958
Trinity Industries
TRN
$2.34B
$1.19M 0.01%
55,980
-358
-0.6% -$6.89K
WDFC icon
959
WD-40
WDFC
$3.09B
$1.19M 0.01%
5,990
+310
+5% +$56.2K
NHI icon
960
National Health Investors
NHI
$3.5B
$1.18M 0.01%
19,484
+1,414
+8% +$77.7K
NUS icon
961
Nu Skin
NUS
$236M
$1.18M 0.01%
30,820
-1,064
-3% -$34.2K
TNET icon
962
TriNet
TNET
$3.22B
$1.18M 0.01%
19,326
UNF icon
963
Unifirst Corp
UNF
$5.21B
$1.18M 0.01%
6,580
+318
+5% +$53.3K
RPD icon
964
Rapid7
RPD
$929M
$1.18M 0.01%
23,076
+1,700
+8% +$79.1K
PLUG icon
965
Plug Power
PLUG
$3.21B
$1.18M 0.01%
143,326
+15,331
+12% +$71.8K
ITRI icon
966
Itron
ITRI
$4.5B
$1.17M 0.01%
17,707
+2,891
+20% +$184K
AEIS icon
967
Advanced Energy
AEIS
$13.2B
$1.17M 0.01%
17,268
+1,400
+9% +$83.4K
MEDP icon
968
Medpace
MEDP
$16.2B
$1.17M 0.01%
12,571
+975
+8% +$83K
JBTM
969
JBT Marel
JBTM
$6.1B
$1.17M 0.01%
13,566
+554
+4% +$43K
CXW icon
970
CoreCivic
CXW
$3.13B
$1.16M 0.01%
124,336
+2,680
+2% +$30.6K
ALK icon
971
Alaska Air
ALK
$5.3B
$1.15M 0.01%
31,791
+42
+0.1% +$1.37K
TDS icon
972
Telephone and Data Systems
TDS
$4.03B
$1.15M 0.01%
57,971
+1,831
+3% +$35K
ACIA
973
DELISTED
Acacia Communications Inc
ACIA
$1.15M 0.01%
17,120
+1,354
+9% +$91.8K
CLDR
974
DELISTED
Cloudera, Inc.
CLDR
$1.15M 0.01%
90,215
-15,752
-15% -$151K
MOS icon
975
The Mosaic Company
MOS
$6.92B
$1.14M 0.01%
91,197
+1,073
+1% +$12.9K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.